Kamada Surges with Record Growth | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded19 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20065494

Show notes

Kamada’s first half of 2026 is exploding with record-breaking growth—revenues up 13% to $100 million, adjusted EBITDA soaring 14% to $25.7 million. Driven by strong sales of key plasma-derived products like KEDRAB and VARIZIG, plus new distribution deals and a $50M plasma supply agreement, the company’s organic momentum is accelerating. CEO Amir London confirms this surge will only intensify with future acquisitions. With Q2 revenue jumping 23% to $54.9M and net income up 26%, Kamada reaffirms its full-year guidance of $200–205M in revenue and remains laser-focused on its four pillars: expanding product sales, growing distribution, boosting plasma collection, and strategic acquisitions—all aimed at delivering consistent double-digit profitable growth for shareholders. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/73aec24d3243d72a

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.